Annual Gross Margin
33.26%
-47.72%-58.93%
31 December 2023
Summary:
Avalo Therapeutics annual gross profit margin is currently 33.26%, with the most recent change of -47.72% (-58.93%) on 31 December 2023. During the last 3 years, it has fallen by -62.26% (-65.18%). AVTX annual gross margin is now -69.31% below its all-time high of 108.39%, reached on 31 December 2019.AVTX Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
386.75%
0.00%
30 September 2024
Summary:
Avalo Therapeutics quarterly gross profit margin is currently 386.75%Over the past year, it has increased by +391.41% (+8399.36%). AVTX quarterly gross margin is now at all-time high.AVTX Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVTX Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.9% | +8399.4% |
| 3 y3 years | -65.2% | +1081.3% |
| 5 y5 years | -38.0% | +311.5% |
AVTX Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.2% | at low | at high | +513.1% |
| 5 y | 5 years | -69.3% | at low | at high | +513.1% |
| alltime | all time | -69.3% | at low | at high | +513.1% |
Avalo Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 386.75%(+178.8%) |
| Dec 2023 | 33.26%(-58.9%) | 138.70%(-3076.4%) |
| Sept 2023 | - | -4.66%(-53.9%) |
| June 2023 | - | -10.11%(-36.8%) |
| Mar 2023 | - | -16.00%(-151.9%) |
| Dec 2022 | 80.98%(+11.9%) | 30.80%(-68.1%) |
| Sept 2022 | - | 96.47%(-286.6%) |
| June 2022 | - | -51.69%(-233.8%) |
| Mar 2022 | - | 38.62%(-141.3%) |
| Dec 2021 | 72.38%(-24.2%) | -93.61%(-385.9%) |
| Sept 2021 | - | 32.74%(-66.4%) |
| June 2021 | - | 97.53%(+16.5%) |
| Mar 2021 | - | 83.72%(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | 95.52%(-11.9%) | 94.72%(+1.8%) |
| Sept 2020 | - | 93.07%(-1.2%) |
| June 2020 | - | 94.17%(-3.5%) |
| Mar 2020 | - | 97.60%(+5.8%) |
| Dec 2019 | 108.39%(+102.2%) | 92.21%(-1.9%) |
| Sept 2019 | - | 93.99%(-54.7%) |
| June 2019 | - | 207.53%(+193.2%) |
| Mar 2019 | - | 70.79%(+7.0%) |
| Dec 2018 | 53.61%(-45.1%) | 66.15%(+179.7%) |
| Sept 2018 | - | 23.65%(-66.3%) |
| June 2018 | - | 70.26%(-13.0%) |
| Mar 2018 | - | 80.73%(+12.8%) |
| Dec 2017 | 97.71% | 71.54% |
FAQ
- What is Avalo Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Avalo Therapeutics?
- What is Avalo Therapeutics annual gross margin year-on-year change?
- What is Avalo Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly gross margin year-on-year change?
What is Avalo Therapeutics annual gross profit margin?
The current annual gross margin of AVTX is 33.26%
What is the all time high annual gross margin for Avalo Therapeutics?
Avalo Therapeutics all-time high annual gross profit margin is 108.39%
What is Avalo Therapeutics annual gross margin year-on-year change?
Over the past year, AVTX annual gross profit margin has changed by -47.72% (-58.93%)
What is Avalo Therapeutics quarterly gross profit margin?
The current quarterly gross margin of AVTX is 386.75%
What is the all time high quarterly gross margin for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly gross profit margin is 386.75%
What is Avalo Therapeutics quarterly gross margin year-on-year change?
Over the past year, AVTX quarterly gross profit margin has changed by +391.41% (+8399.36%)